Weill Cornell Medicine
Assistant Professor at Weill Cornell Medicine
Dr. Hsu graduated from UC Berkeley with a Bachelor degree (honors) in Biochemistry/Molecular Biology in 2000. He later received both MD and PhD (in Immunology) degrees from The University of Texas Medical School at Houston/MD Anderson Cancer Center. Subsequently he completed the Clinical Pathology residency program at Washington University School of Medicine and the Transfusion Medicine Fellowship program at UCSF Medical Center. Dr. Hsu joined the Weill Cornell Medicine faculty as an Assistant Professor in 2014 and accomplished an monumental task of developing a brand new cGMP Cellular Therapy Laboratory (AKA Laboratory for Advanced Cellular Engineering, LACE) at Cornell in 2017. Nationally recognized, Dr. Hsu has a strong research interest in the manufacturing of novel blood and cellular therapy products and investigating the clinical utilities of these novel cell products impacting on human health. He also receives extramural funding to develop novel diagnostic platforms to evaluate the qualities in various types of stem cells used clinically. Since 2014, Dr. Hsu has been providing medical/operational oversights for CAP, NYS/CLIA, AABB, FACT certified/ accredited blood bank and cellular therapy laboratories at the NewYork-Presbyterian Hospital-Cornell. Currently he is the Laboratory Director of LACE. For education, Dr. Hsu also serves an Assistant Director for the Weill Cornell Medicine Pathology Residency Training Program. Highlighting a few of his administrative roles at various professional societies, Dr. Hsu serves as a FACT Cell Processing Laboratory inspector and a member/leader in AABB Cellular Therapy Accreditation Program Unit, Section Coordinating Committee, Product Manufacturing and Testing subsection, and Asian Pacific Group subsections. Dr. Hsu is particularly interested in sharing his expertise and experience with colleagues to advocate the continuing development of cellular therapy in the Asia Pacific region.